The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Camoquin     4-[(7-chloroquinolin-4- yl)amino]-2...

Synonyms: Basoquin, Camochin, Camoquine, Flavoquin, Amodiachin, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Camoquine


High impact information on Camoquine


Chemical compound and disease context of Camoquine


Biological context of Camoquine


Anatomical context of Camoquine


Associations of Camoquine with other chemical compounds


Gene context of Camoquine


Analytical, diagnostic and therapeutic context of Camoquine


  1. Systematic review of amodiaquine treatment in uncomplicated malaria. Olliaro, P., Nevill, C., LeBras, J., Ringwald, P., Mussano, P., Garner, P., Brasseur, P. Lancet (1996) [Pubmed]
  2. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Hatton, C.S., Peto, T.E., Bunch, C., Pasvol, G., Russell, S.J., Singer, C.R., Edwards, G., Winstanley, P. Lancet (1986) [Pubmed]
  3. Atovaquone and proguanil for Plasmodium falciparum malaria. Radloff, P.D., Philipps, J., Nkeyi, M., Hutchinson, D., Kremsner, P.G. Lancet (1996) [Pubmed]
  4. Amodiaquine-induced hepatitis. A report of seven cases. Larrey, D., Castot, A., Pëssayre, D., Merigot, P., Machayekhy, J.P., Feldmann, G., Lenoir, A., Rueff, B., Benhamou, J.P. Ann. Intern. Med. (1986) [Pubmed]
  5. Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives. Good, M.I., Shader, R.I. The American journal of psychiatry. (1977) [Pubmed]
  6. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Adjuik, M., Agnamey, P., Babiker, A., Borrmann, S., Brasseur, P., Cisse, M., Cobelens, F., Diallo, S., Faucher, J.F., Garner, P., Gikunda, S., Kremsner, P.G., Krishna, S., Lell, B., Loolpapit, M., Matsiegui, P.B., Missinou, M.A., Mwanza, J., Ntoumi, F., Olliaro, P., Osimbo, P., Rezbach, P., Some, E., Taylor, W.R. Lancet (2002) [Pubmed]
  7. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Watkins, W.M., Sixsmith, D.G., Spencer, H.C., Boriga, D.A., Kariuki, D.M., Kipingor, T., Koech, D.K. Lancet (1984) [Pubmed]
  8. 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake. Bray, P.G., Hawley, S.R., Ward, S.A. Mol. Pharmacol. (1996) [Pubmed]
  9. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA. Girard, B., Otterness, D.M., Wood, T.C., Honchel, R., Wieben, E.D., Weinshilboum, R.M. Mol. Pharmacol. (1994) [Pubmed]
  10. Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria. Looareesuwan, S., Phillips, R.E., White, N.J., Karbwang, J., Benjasurat, Y., Attanath, P., Warrell, D.A. Lancet (1985) [Pubmed]
  11. Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Aubouy, A., Bakary, M., Keundjian, A., Mbomat, B., Makita, J.R., Migot-Nabias, F., Cot, M., Le Bras, J., Deloron, P. Antimicrob. Agents Chemother. (2003) [Pubmed]
  12. Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component. Hawley, S.R., Bray, P.G., O'Neill, P.M., Naisbitt, D.J., Park, B.K., Ward, S.A. Antimicrob. Agents Chemother. (1996) [Pubmed]
  13. Prevention of malaria. Keystone, J.S. Drugs (1990) [Pubmed]
  14. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Krishna, S., White, N.J. Clinical pharmacokinetics. (1996) [Pubmed]
  15. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. Alifrangis, M., Dalgaard, M.B., Lusingu, J.P., Vestergaard, L.S., Staalsoe, T., Jensen, A.T., Enevold, A., Rønn, A.M., Khalil, I.F., Warhurst, D.C., Lemnge, M.M., Theander, T.G., Bygbjerg, I.C. J. Infect. Dis. (2006) [Pubmed]
  16. Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitro. Labro, M.T., el Benna, J. Antimicrob. Agents Chemother. (1991) [Pubmed]
  17. Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malaria. Mawili-Mboumba, D.P., Borrmann, S., Cavanagh, D.R., McBride, J.S., Matsiegui, P.B., Missinou, M.A., Kremsner, P.G., Ntoumi, F. J. Infect. Dis. (2003) [Pubmed]
  18. Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Labro, M.T., Babin-Chevaye, C. Antimicrob. Agents Chemother. (1988) [Pubmed]
  19. Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines. Delarue, S., Girault, S., Maes, L., Debreu-Fontaine, M.A., Labaeïd, M., Grellier, P., Sergheraert, C. J. Med. Chem. (2001) [Pubmed]
  20. Amodiaquin accumulation by mouse erythrocytes infected with Plasmodium berghei. Fitch, C.D., Gonzalez, Y., Chevli, R. J. Pharmacol. Exp. Ther. (1975) [Pubmed]
  21. Effect of amodiaquine on gastric histamine methyltransferase and on histamine-stimulated gastric secretion. Barth, H., Lorenz, W., Troidl, H. Br. J. Pharmacol. (1975) [Pubmed]
  22. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Ginsburg, H., Famin, O., Zhang, J., Krugliak, M. Biochem. Pharmacol. (1998) [Pubmed]
  23. Antiparasitic properties of medicinal plants and other naturally occurring products. Tagboto, S., Townson, S. Advances in parasitology. (2001) [Pubmed]
  24. The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: chemical mechanisms and the effects of fluorine substitution. Tingle, M.D., Jewell, H., Maggs, J.L., O'Neill, P.M., Park, B.K. Biochem. Pharmacol. (1995) [Pubmed]
  25. Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. Li, X.Q., Björkman, A., Andersson, T.B., Ridderström, M., Masimirembwa, C.M. J. Pharmacol. Exp. Ther. (2002) [Pubmed]
  26. Influence of amodiaquine treatment on microsomal lipid peroxidation and antioxidant defense systems of rats. Farombi, E.O. Pharmacol. Toxicol. (2000) [Pubmed]
  27. The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Harrison, A.C., Kitteringham, N.R., Clarke, J.B., Park, B.K. Biochem. Pharmacol. (1992) [Pubmed]
  28. Drug-protein conjugates--XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat. Christie, G., Breckenridge, A.M., Park, B.K. Biochem. Pharmacol. (1989) [Pubmed]
  29. Reactions of a free radical intermediate in the oxidation of amodiaquine. Bisby, R.H. Biochem. Pharmacol. (1990) [Pubmed]
  30. The disposition of amodiaquine in man after oral administration. Winstanley, P., Edwards, G., Orme, M., Breckenridge, A. British journal of clinical pharmacology. (1987) [Pubmed]
  31. Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods. Churchill, F.C., Mount, D.L., Patchen, L.C., Björkman, A. J. Chromatogr. (1986) [Pubmed]
WikiGenes - Universities